Intratumoral γδ T-cell infiltrates, CCL4/5 protein expression and survival in patients with hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2020 at "Hepatology"
DOI: 10.1002/hep.31412
Abstract: Hepatocellular carcinoma (HCC) is an aggressive malignancy which is often associated with a complex tumor microenvironment due to etiology-induced cellular inflammation. γδ T-cells are known to detect and react to chronic inflammation, which is linked… read more here.
Keywords: hepatocellular carcinoma; hcc patients; expression; cell ... See more keywords
Four differentially methylated gene pairs to predict the prognosis for early stage hepatocellular carcinoma patients
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cellular Physiology"
DOI: 10.1002/jcp.26256
Abstract: Hepatocellular carcinoma (HCC) was the second most common malignant tumor with a poor prognostic condition. We aimed to identify novel methylation signatures to predict HCC patients at their early stages. Differentially expressed methylated genes between… read more here.
Keywords: hepatocellular carcinoma; hcc; hcc patients; differentially methylated ... See more keywords
The landscape of DNA methylation in hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cellular Physiology"
DOI: 10.1002/jcp.27077
Abstract: Better understanding of the relationship between changes in the overall methylation status of hepatocellular carcinoma (HCC) and disease progression will help us find good strategies for the early detection and treatment of HCC patients. The… read more here.
Keywords: hepatocellular carcinoma; methylation; hcc; hcc patients ... See more keywords
TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension
Sign Up to like & getrecommendations! Published in 2022 at "European Radiology"
DOI: 10.1007/s00330-022-08705-7
Abstract: Portal vein tumour thrombus (PVTT)–related symptomatic portal hypertension (SPH) leads to a poor prognosis in hepatocellular carcinoma (HCC) patients. A transjugular intrahepatic portosystemic shunt (TIPS) can effectively relieve SPH but its effect remains unclear in… read more here.
Keywords: group; systemic therapy; hcc patients; sequential systemic ... See more keywords
Hepatic Arterioportal Fistula Is Associated with Decreased Future Liver Remnant Regeneration after Stage-I ALPPS for Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-021-05022-0
Abstract: Hepatocellular carcinoma (HCC) patients often developed hepatic arterioportal fistula (APF). The aim of this study is to evaluate the impact of APF on future liver remnant (FLR) regeneration and surgical outcomes after the first stage… read more here.
Keywords: hepatocellular carcinoma; regeneration; group; stage alpps ... See more keywords
Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Gastrointestinal Cancer"
DOI: 10.1007/s12029-017-9937-6
Abstract: Background and AimExtremely poor prognosis in hepatocellular carcinoma (HCC) patients with progressing disease was denoted by vascular invasion. Cytokeratin 18 (CK18) has been shown to be overexpressed in hepatocellular carcinoma so it is a valuable… read more here.
Keywords: invasion; hepatocellular carcinoma; macrovascular invasion; hcc patients ... See more keywords
SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Gastrointestinal Cancer"
DOI: 10.1007/s12029-017-9990-1
Abstract: PurposeThe study aimed to evaluate stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC) in patients not eligible for liver transplant (LT).MethodsWe retrospectively identified transplant-ineligible HCC patients treated with SBRT to the liver between 2004 and… read more here.
Keywords: hepatocellular carcinoma; year; sbrt hepatocellular; hcc patients ... See more keywords
Potential use of TIA-1, MFF, microRNA-200a-3p, and microRNA-27 as a novel marker for hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2018 at "Biochemical and biophysical research communications"
DOI: 10.1016/j.bbrc.2018.02.189
Abstract: Precise and early diagnosis is critical to improve the survival rate of hepatocellular carcinoma (HCC) patients. Although several genetic and protein markers have been developed and are currently used for diagnosis, prognosis, risk stratification, and… read more here.
Keywords: hepatocellular carcinoma; liver tissues; tia mff; hcc patients ... See more keywords
Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression.
Sign Up to like & getrecommendations! Published in 2022 at "Chemico-biological interactions"
DOI: 10.1016/j.cbi.2022.109847
Abstract: Bile acids (BAs), the most important components of bile, attribute predominately to maintain metabolic homeostasis. In hepatocellular carcinoma (HCC) patients, the BAs homeostasis was seriously disturbed, especially in those patients with alcohol-intake history. However, whether… read more here.
Keywords: hcc patients; hepatocellular carcinoma; alcohol; homeostasis ... See more keywords
329. Personalized dosimetric approach in advanced HCC patients treated with 90Y resin microspheres
Sign Up to like & getrecommendations! Published in 2018 at "Physica Medica"
DOI: 10.1016/j.ejmp.2018.04.338
Abstract: Purpose Radioembolization with 90Y resin microspheres is becoming an effective therapeutic option for advanced HCC patients. Dosimetric methods are compared to standard ones to highlight the relevance of a personalized approach. Methods The study was… read more here.
Keywords: hcc patients; 90y resin; resin microspheres; approach ... See more keywords
Serum AKR1B10 predicts the risk of hepatocellular carcinoma - A retrospective single-center study.
Sign Up to like & getrecommendations! Published in 2019 at "Gastroenterologia y hepatologia"
DOI: 10.1016/j.gastrohep.2019.06.007
Abstract: OBJECTIVES AKR1B10, first cloned from liver cancer tissues, has recently been reported to be up-regulated significantly in hepatocellular carcinoma (HCC) tissues, but the relationship between serum level of AKR1B10 and the risk of HCC is… read more here.
Keywords: hepatocellular carcinoma; serum akr1b10; hcc; hcc patients ... See more keywords